Onc Now
In this episode of Onc Now, Lennard Lee explores the latest advances in personalised cancer vaccines, emerging clinical evidence, and the potential of agentic AI scientists to accelerate cancer discovery, trans-form drug development and shape the future of oncology.
Speaker bio:
Lennard Lee is an Associate Professor in the Nuffield Department of Medicine at the University of Oxford and a Consultant Medical Oncol-ogist at Oxford University Hospitals NHS Foundation Trust, UK. His work focuses on cancer research, emerging technologies, and personal-ised cancer vaccines.
Timestamps:
00:00 – Introduction
00:55 – Origin of interest in cancer vaccines
02:40 – Latest developments in cancer vaccines
04:30 – Who benefits from cancer vaccines?
09:45 – Expanding access to cancer vaccines
13:35 – AI and personalised vaccine development
20:55 – Oxford’s AI cancer scientist initiative
24:25 – AI’s impact beyond cancer vaccines
29:30 – Three wishes for cancer’s future
Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.
